Immatics N.V. Warrants
-$0.40 (-12.31%) Today
$0.00 (0.00%) As of 11:59 PM UTC after-hours
Why Robinhood?
You can watch IMTXW and buy or sell other stocks, options, and ETFs commission-free!
About IMTXW
Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. The firm's clinical pipelines include adoptive cell therapy (ACT) and TCR biscpecifics (TCERâ„¢).
CEO
Harpreet Singh-Jasuja, PhD
Employees
—
Headquarters
Tuebingen, Baden Wuerttemberg
Founded
2020
IMTXW Key Statistics
Market Cap
—
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
15.04K
High Today
$3.24
Low Today
$2.81
Open Price
$3.24
Volume
16.11K
52 Week High
$8.49
52 Week Low
$1.67